Overview

Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19

Status:
Completed
Trial end date:
2020-08-30
Target enrollment:
Participant gender:
Summary
Q-PROTECT is a placebo controlled randomized trial (RCT) to ascertain the efficacy of hydroxychloroquine (HC) alone or, in combination with azithromycin (AZ), in reducing viral load in patients with COVID 19.
Phase:
N/A
Details
Lead Sponsor:
Hamad Medical Corporation
Treatments:
Azithromycin
Hydroxychloroquine